Life Sciences Tools and Services
Company Overview of Davos Chemical Corporation
Davos Chemical Corporation provides chemistry and pharmaceutical services for biotechs and pharmaceutical companies in United States, Europe, and Asia. The company offers drug substance and drug products in the areas of preclinical/clinical supply, commercial manufacture, and cytotoxics and other compounds; documentation preparation and support services; oral and parenteral clinical trial materials; synthesized materials, including APIs and intermediates; analytical services, such as methods development, testing, and validation; preformulation and formulation development services; chemistry development and optimization services; and medicinal chemistry and biology discovery services. Davos C...
600 East Crescent Avenue
Upper Saddle River, NJ 07458
Founded in 1972
Key Executives for Davos Chemical Corporation
Chief Financial Officer and Executive Vice President
Director of Import and Export Logistics
Vice President of Chemistry
Compensation as of Fiscal Year 2015.
Davos Chemical Corporation Key Developments
AV Therapeutics Announces Collaboration with DavosPharma to Manufacture Chemotherapeutic Drug Capridine
Feb 5 14
AV Therapeutics, Inc. announced that it has entered into an agreement with DavosPharma, to assist in the Good Manufacturing Practices (GMP) synthesis of its lead drug candidate Capridine. DavosPharma is expected to complete the manufacturing of the drug in the 2nd quarter of 2014. The Company is also in the process of preparing its Investigational New Drug (IND) application for the FDA. AV Therapeutics is hopeful that it can begin its Phase I clinical trial in the 4(th) quarter. Phase I clinical trials will be managed by a consortium of hospitals including Memorial Sloan Kettering Cancer Center. This will facilitate expeditious experimental results. Capridine has been shown to have specific activity towards both hormone dependent and independent prostate cancer and minimal bone marrow toxicity in preclinical studies conducted by AV Therapeutics. If successful Capridine will be the adjuvant chemotherapeutic drug for all stages of prostate cancer. first of its kind.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries